|3Nov 27, 4:43 PM ET

Ridge Valley Corp 3

3 · Wize Pharma, Inc. · Filed Nov 27, 2017

Insider Transaction Report

Form 3
Period: 2017-11-16
Holdings
  • 2017 Convertible Notes

    Exercise: $0.50From: 2017-04-02Exp: 2017-12-31Common Stock, par value $0.001 per share (6,075,903 underlying)
  • Future Investment Rights

    Exercise: $0.60From: 2017-04-02Exp: 2017-06-30Common Stock, par value $0.001 per share (7,401,034 underlying)
  • Common Stock, par value $0.001 per share

    19,853,641

Documents

1 file
  • 3
    f3111617ridgevalley_wize.xmlPrimary

    OWNERSHIP DOCUMENT